Articles Archives
Articles
07/07/2026
Cryoport Systems Wins Best Cell & Gene Therapy Supplier Award for Cold Chain Logistics at APCGTEA 2026
Cryoport Systems is pleased to announce that we have been named Best Cell & Gene Therapy Supplier – Cold Chain Logistics at the 2026 Asia-Pacific Cell & Gene Therapy Excellence Awards (APCGTEA). This recognition carries special meaning as it reflects the voice of the global advanced therapies community.
Animal Pharmaceuticals
07/07/2026
Scaling Animal Health Programs Shouldn’t Mean Requalifying Your Supply Chain
Animal health programs tend to reveal their logistics weaknesses at the point of growth. A process that feels manageable when a therapy, vaccine, biologic, or reproductive material is moving between a limited number of familiar sites can become difficult to defend once the same program expands across facilities, regions, partners, or countries. The science may be ready to scale, but the operational framework often has to prove that it can scale with it.
Animal Health
05/21/2026
Lane Qualification Reduces Risk Before Shipments Move
Animal health biopharmaceutical programs put pressure on logistics networks in ways that standard route planning doesn’t always capture. Vaccines may move in defined seasonal windows, while monoclonal antibodies (mAbs), cell-based therapies, biologics, and other sensitive materials may move through channels with different timing constraints. Some shipments are tied to manufacturing release, others are tied to clinical study schedules, and still others are fitting into regional disease control programs or veterinary network demand.
Animal Health
04/21/2026
Validated Shipping Systems are the Foundation of Risk-Mitigated Animal Health Logistics
Animal health logistics are entering a phase where variability is no longer tolerable. Vaccines, biologics, reproductive materials, and advanced therapies are sensitive to critical parameters like temperature and handling conditions, and as regulatory expectations continue to move toward tighter controls and clearer documentation, shipping has become so much more than a support function.
Animal Health
03/19/2026
The Visibility and Traceability Animal Health Programs Need
Temperature-sensitive materials now move through animal health programs in far greater volumes, and that shift has raised the bar for how their transit needs to be documented. Teams responsible for oversight want documentation that reflects actual handling conditions from origin to delivery, with enough detail to support a clear assessment of risk. While the regulatory environment for animal health lags behind that for human health, programs are increasingly expected to provide records that reflect the actual conditions and custody of the material throughout transit.
Animal Pharmaceuticals
09/16/2025
Temperature-Controlled Shipping: A Lifeline for Animal Health Companies
For animal health companies, the success of a product is determined long before it reaches the veterinary clinic, farm, or research facility. No matter how innovative a vaccine, biologic, or next-gen therapy may be, its ultimate impact depends on maintaining its integrity during transportation. Temperature-controlled logistics are no longer a back-office concern, they have become a core element of success that impacts product efficacy, regulatory compliance, and even operational efficiency.
Industry Insights
07/22/2025
What’s Next for the CGT Industry? Mid-Year Check-In from the Leadership Team
We’re halfway through 2025, and the cell and gene therapy (CGT) landscape stands at a crossroads. Innovation continues to advance, yet the infrastructure required to support commercialization remains under pressure. To assess the current state of the industry and what’s ahead, Cryoport Systems gathered candid insights from our internal leaders across functions, from product development and commercial strategy to operations and client engagement.
Managing the Cold Chain
06/28/2025
Celebrating Logistics, the Unsung Hero in Cell and Gene Therapy Innovation
Every National Logistics Day offers a chance to recognize the systems and people that quietly power the innovation engine for Cell and Gene Therapy (CGT). While logistics frequently brings to mind images of trucks and warehouses, cardboard boxes, and tracking numbers, for CGT developers, it’s the infrastructure that protects innovation and ensures that time-sensitive, potentially life-changing treatments reach patients intact and on time. At Cryoport Systems, logistics has never been just about transportation. It’s about Enabling the Outcome™.
Navigating Logistics
06/27/2025